𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?

✍ Scribed by Baltasar Pérez Saborido; Juan Carlos Meneu; Enrique Moreno; Ignacio García; Almudena Moreno; Yilian Fundora

Book ID
116215207
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
159 KB
Volume
190
Category
Article
ISSN
0002-9610

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mixed phenotype hepatocellular carcinoma
Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation
✍ Chikako Zen; Yoh Zen; Ragai R. Mitry; Denis Corbeil; Jana Karbanová; John O'Grad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

We investigated the phenotype of hepatocellular carcinoma (HCC) in livers removed during transplantation after local ablation therapy by transarterial chemoembolization (TACE). This study involved 80 HCC nodules (40 treated with TACE and 40 not treated with local ablation before transplantation) obs

Comparison of two techniques of transart
Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: A case-control study
✍ Sébastien Dharancy; Jeanne Boitard; Thomas Decaens; Géraldine Sergent; Emmanuel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Supraselective transarterial chemoembolization (STACE) more efficiently targets chemotherapy delivered via the feeding arterial branches of the tumor than does conventional transarterial chemoembolization (TACE). However, the hypothesis of its greater efficacy compared with the latter is subject to